
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Going beyond the liver: Progress and challenges of targeted delivery of siRNA therapeutics
Cornelia Lorenzer, Mehrdad Dirin, Anna-Maria Winkler, et al.
Journal of Controlled Release (2015) Vol. 203, pp. 1-15
Open Access | Times Cited: 263
Cornelia Lorenzer, Mehrdad Dirin, Anna-Maria Winkler, et al.
Journal of Controlled Release (2015) Vol. 203, pp. 1-15
Open Access | Times Cited: 263
Showing 1-25 of 263 citing articles:
Emerging Frontiers in Drug Delivery
Mark W. Tibbitt, James E. Dahlman, Róbert Langer
Journal of the American Chemical Society (2016) Vol. 138, Iss. 3, pp. 704-717
Closed Access | Times Cited: 885
Mark W. Tibbitt, James E. Dahlman, Róbert Langer
Journal of the American Chemical Society (2016) Vol. 138, Iss. 3, pp. 704-717
Closed Access | Times Cited: 885
The delivery of therapeutic oligonucleotides
Rudolph L. Juliano
Nucleic Acids Research (2016) Vol. 44, Iss. 14, pp. 6518-6548
Open Access | Times Cited: 730
Rudolph L. Juliano
Nucleic Acids Research (2016) Vol. 44, Iss. 14, pp. 6518-6548
Open Access | Times Cited: 730
Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting
Seung Min Kim, Yoosoo Yang, Seung Ja Oh, et al.
Journal of Controlled Release (2017) Vol. 266, pp. 8-16
Closed Access | Times Cited: 399
Seung Min Kim, Yoosoo Yang, Seung Ja Oh, et al.
Journal of Controlled Release (2017) Vol. 266, pp. 8-16
Closed Access | Times Cited: 399
Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
Karishma Dhuri, Clara Bechtold, Elias Quijano, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 2004-2004
Open Access | Times Cited: 383
Karishma Dhuri, Clara Bechtold, Elias Quijano, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 2004-2004
Open Access | Times Cited: 383
Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives
Wolfgang Poller, Stefanie Dimmeler, Stéphane Heymans, et al.
European Heart Journal (2017) Vol. 39, Iss. 29, pp. 2704-2716
Open Access | Times Cited: 371
Wolfgang Poller, Stefanie Dimmeler, Stéphane Heymans, et al.
European Heart Journal (2017) Vol. 39, Iss. 29, pp. 2704-2716
Open Access | Times Cited: 371
Targeted gene silencing in vivo by platelet membrane–coated metal-organic framework nanoparticles
Jia Zhuang, Hua Gong, Jiarong Zhou, et al.
Science Advances (2020) Vol. 6, Iss. 13
Open Access | Times Cited: 282
Jia Zhuang, Hua Gong, Jiarong Zhou, et al.
Science Advances (2020) Vol. 6, Iss. 13
Open Access | Times Cited: 282
Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery
Jonas Buck, Philip Grossen, Pieter R. Cullis, et al.
ACS Nano (2019) Vol. 13, Iss. 4, pp. 3754-3782
Closed Access | Times Cited: 274
Jonas Buck, Philip Grossen, Pieter R. Cullis, et al.
ACS Nano (2019) Vol. 13, Iss. 4, pp. 3754-3782
Closed Access | Times Cited: 274
Emerging Concepts and Technologies in Vaccine Development
Morgan Brisse, Sophia M. Vrba, Natalie M. Kirk, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 256
Morgan Brisse, Sophia M. Vrba, Natalie M. Kirk, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 256
Oligonucleotide Therapies: The Past and the Present
Karin E. Lundin, Olof Gissberg, Smith Rjh
Human Gene Therapy (2015) Vol. 26, Iss. 8, pp. 475-485
Open Access | Times Cited: 249
Karin E. Lundin, Olof Gissberg, Smith Rjh
Human Gene Therapy (2015) Vol. 26, Iss. 8, pp. 475-485
Open Access | Times Cited: 249
Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer
Yongjiang Li, Junyong Wu, Jiemin Wang, et al.
Acta Biomaterialia (2019) Vol. 101, pp. 519-530
Closed Access | Times Cited: 243
Yongjiang Li, Junyong Wu, Jiemin Wang, et al.
Acta Biomaterialia (2019) Vol. 101, pp. 519-530
Closed Access | Times Cited: 243
Safety of antisense oligonucleotide and siRNA-based therapeutics
Xuan Chi, Philip Gatti, Thomas Papoian
Drug Discovery Today (2017) Vol. 22, Iss. 5, pp. 823-833
Closed Access | Times Cited: 231
Xuan Chi, Philip Gatti, Thomas Papoian
Drug Discovery Today (2017) Vol. 22, Iss. 5, pp. 823-833
Closed Access | Times Cited: 231
Nucleic acid delivery for therapeutic applications
Akash Gupta, Jason L. Andresen, Rajith S. Manan, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113834-113834
Closed Access | Times Cited: 219
Akash Gupta, Jason L. Andresen, Rajith S. Manan, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113834-113834
Closed Access | Times Cited: 219
Super-resolution Imaging of Proton Sponge-Triggered Rupture of Endosomes and Cytosolic Release of Small Interfering RNA
Marcin Wojnilowicz, Agata Glab, Alessandro Bertucci, et al.
ACS Nano (2018) Vol. 13, Iss. 1, pp. 187-202
Open Access | Times Cited: 202
Marcin Wojnilowicz, Agata Glab, Alessandro Bertucci, et al.
ACS Nano (2018) Vol. 13, Iss. 1, pp. 187-202
Open Access | Times Cited: 202
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
Changyu Zhu, KyeongJin Kim, Xiaobo Wang, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 468
Open Access | Times Cited: 199
Changyu Zhu, KyeongJin Kim, Xiaobo Wang, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 468
Open Access | Times Cited: 199
<p>Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach</p>
Ghanbar Mahmoodi Chalbatani, Hassan Dana, Elahe Gharagouzloo, et al.
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 3111-3128
Open Access | Times Cited: 199
Ghanbar Mahmoodi Chalbatani, Hassan Dana, Elahe Gharagouzloo, et al.
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 3111-3128
Open Access | Times Cited: 199
Paving the Road for RNA Therapeutics
Niels Dammes, Dan Peer
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 10, pp. 755-775
Open Access | Times Cited: 187
Niels Dammes, Dan Peer
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 10, pp. 755-775
Open Access | Times Cited: 187
The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
Ricardo Titze‐de‐Almeida, Catherine David, Simoneide Souza Titze-de-Almeida
Pharmaceutical Research (2017) Vol. 34, Iss. 7, pp. 1339-1363
Closed Access | Times Cited: 183
Ricardo Titze‐de‐Almeida, Catherine David, Simoneide Souza Titze-de-Almeida
Pharmaceutical Research (2017) Vol. 34, Iss. 7, pp. 1339-1363
Closed Access | Times Cited: 183
Nonviral Gene Delivery with Cationic Glycopolymers
Craig Van Bruggen, Joseph K. Hexum, Zhe Tan, et al.
Accounts of Chemical Research (2019) Vol. 52, Iss. 5, pp. 1347-1358
Open Access | Times Cited: 146
Craig Van Bruggen, Joseph K. Hexum, Zhe Tan, et al.
Accounts of Chemical Research (2019) Vol. 52, Iss. 5, pp. 1347-1358
Open Access | Times Cited: 146
Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo
Huanzhen Ni, Marine Z. C. Hatit, Kun Zhao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 105
Huanzhen Ni, Marine Z. C. Hatit, Kun Zhao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 105
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
Savan K. Patel, Margaret M. Billingsley, C. Pritchett Frazee, et al.
Journal of Controlled Release (2022) Vol. 347, pp. 521-532
Open Access | Times Cited: 75
Savan K. Patel, Margaret M. Billingsley, C. Pritchett Frazee, et al.
Journal of Controlled Release (2022) Vol. 347, pp. 521-532
Open Access | Times Cited: 75
Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections
Alex Abramson, Ameya R. Kirtane, Yunhua Shi, et al.
Matter (2022) Vol. 5, Iss. 3, pp. 975-987
Open Access | Times Cited: 69
Alex Abramson, Ameya R. Kirtane, Yunhua Shi, et al.
Matter (2022) Vol. 5, Iss. 3, pp. 975-987
Open Access | Times Cited: 69
Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids
Monique Culturato Padilha Mendonça, Ayse Kont, Piotr S. Kowalski, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 3, pp. 103505-103505
Open Access | Times Cited: 53
Monique Culturato Padilha Mendonça, Ayse Kont, Piotr S. Kowalski, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 3, pp. 103505-103505
Open Access | Times Cited: 53
Journey of siRNA: Clinical Developments and Targeted Delivery
Rahul R. Nikam, Kiran R. Gore
Nucleic Acid Therapeutics (2018) Vol. 28, Iss. 4, pp. 209-224
Closed Access | Times Cited: 156
Rahul R. Nikam, Kiran R. Gore
Nucleic Acid Therapeutics (2018) Vol. 28, Iss. 4, pp. 209-224
Closed Access | Times Cited: 156
Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent
Robert G. Gish, Man‐Fung Yuen, Henry Lik‐Yuen Chan, et al.
Antiviral Research (2015) Vol. 121, pp. 97-108
Open Access | Times Cited: 126
Robert G. Gish, Man‐Fung Yuen, Henry Lik‐Yuen Chan, et al.
Antiviral Research (2015) Vol. 121, pp. 97-108
Open Access | Times Cited: 126
Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting Ligands
Melissa P. Lokugamage, Cory D. Sago, Zubao Gan, et al.
Advanced Materials (2019) Vol. 31, Iss. 41
Open Access | Times Cited: 125
Melissa P. Lokugamage, Cory D. Sago, Zubao Gan, et al.
Advanced Materials (2019) Vol. 31, Iss. 41
Open Access | Times Cited: 125